BioCentury | Jul 18, 2005
Clinical News

Varisolve: IND accepted

...II study protocol submitted by BGC's subsidiary Provensis. The approval was granted after FDA reviewed Provensis'...
BioCentury | Oct 4, 2004
Clinical News

Varisolve update

...on Varisolve due to concerns about the potential risks of gas embolism. BGC said its Provensis Ltd....
...studies as well as a clinical study to generate the information required by the FDA. Provensis...
...in January 2005. If positive, the second part of the study will be conducted and Provensis...
BioCentury | Feb 16, 2004
Clinical News

Varisolve endovenous microfoam for sclerotherapy regulatory update

...BGC said its Provensis Ltd subsidiary plans to respond by November to an FDA clinical hold...
BioCentury | Feb 12, 2004
Financial News

BTG seeking L26.7M financing

...held. CS First Boston is the underwriter. BGC will use the proceeds to fund its Provensis...
Items per page:
1 - 4 of 4
BioCentury | Jul 18, 2005
Clinical News

Varisolve: IND accepted

...II study protocol submitted by BGC's subsidiary Provensis. The approval was granted after FDA reviewed Provensis'...
BioCentury | Oct 4, 2004
Clinical News

Varisolve update

...on Varisolve due to concerns about the potential risks of gas embolism. BGC said its Provensis Ltd....
...studies as well as a clinical study to generate the information required by the FDA. Provensis...
...in January 2005. If positive, the second part of the study will be conducted and Provensis...
BioCentury | Feb 16, 2004
Clinical News

Varisolve endovenous microfoam for sclerotherapy regulatory update

...BGC said its Provensis Ltd subsidiary plans to respond by November to an FDA clinical hold...
BioCentury | Feb 12, 2004
Financial News

BTG seeking L26.7M financing

...held. CS First Boston is the underwriter. BGC will use the proceeds to fund its Provensis...
Items per page:
1 - 4 of 4